Report cover image

U.S. Exosomes Market

Publisher Grand View Research
Published Jan 07, 2026
Length 90 Pages
SKU # GV20873115

Description

U.S. Exosomes Market Summary

The U.S. exosomes market size was estimated at USD 115.6 million in 2025 and is projected to reach USD 716.8 million by 2033, growing at a CAGR of 25.75% from 2026 to 2033. Exosome applications are advancing, which is driving market growth. Technological advancements in exosome isolation and analytical procedures are contributing to market growth and are fueled by the increasing prevalence of cancer.

Increasing Prevalence of Cancer

The increasing prevalence of cancer is one of the key factors contributing to market growth over the forecast period. In 2025, an estimated over 2 million new cancer cases were diagnosed in the U.S. alone. The table below demonstrates the new cancer cases and cancer-related deaths estimated in the U.S. in 2025.

Exosomes have gained attention for their potential as biomarkers for early cancer detection, monitoring disease progression, and assessing therapeutic responses. With the global incidence of cancer on the rise, there is an increasing need for advanced diagnostic tools and targeted treatments, the development of which can be facilitated by exosome-based technologies.

U.S. Exosomes Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the U.S. exosomes market based on product & service, application, workflow, and end use:
  • Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Kits & reagents
  • Instruments
  • Services
  • Workflow Outlook (Revenue, USD Million, 2021 - 2033)
  • Isolation Methods
  • Ultracentrifugation
  • Immunocapture on beads
  • Precipitation
  • Filtration
  • Others
  • Downstream Analysis
  • Cell surface marker analysis using flow cytometry
  • Protein Analysis using blotting & ELISA
  • RNA analysis with NGS & PCR
  • Proteomic analysis using mass spectroscopy
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Cancer
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostics Centers
  • Academic & Research Institutes
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

90 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Application Segment
1.1.2. Product & Service Segment
1.1.3. Workflow Segment
1.1.4. End Use Segment
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Primary Research
1.5. Information or Data Analysis:
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objective
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables & Trends
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Technological advancements in exosomes isolation and analytical procedures
3.2.1.2. Advanced applications of exosomes
3.2.1.3. Growth in strategic initiatives for exosome-based therapies
3.2.1.4. Increasing prevalence of cancer
3.2.2. Market Restraint Analysis
3.2.2.1. Stringent regulations pertaining to approval
3.2.2.2. Challenges associated with the implementation of exosome-based therapies
3.2.2.3. Reduction in funding for biomedical research
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
Chapter 4. U.S. Exosomes Market Product & Service Estimates & Trend Analysis
4.1. U.S. Exosomes Product & Service Dashboard
4.2. U.S. Exosomes Product & Service Movement Analysis
4.3. Kits & Reagents
4.3.1. Kits & Reagents Market, 2021 - 2033 (USD Million)
4.4. Instruments
4.4.1. Instruments Market, 2021 - 2033 (USD Million)
4.5. Services
4.5.1. Services Market, 2021 - 2033 (USD Million)
Chapter 5. U.S. Exosomes Market Application & Trend Analysis
5.1. U.S. Exosomes Market Application Dashboard
5.2. U.S. Exosomes Market Application Movement Analysis
5.3. Cancer
5.3.1. Cancer Market, 2021 - 2033 (USD Million)
5.4. Neurodegenerative Diseases
5.4.1. Neurodegenerative Diseases Market, 2021 - 2033 (USD Million)
5.5. Cardiovascular Diseases
5.5.1. Cardiovascular Diseases Market, 2021 - 2033 (USD Million)
5.6. Infectious Diseases
5.6.1. Infectious Diseases Market, 2021 - 2033 (USD Million)
5.7. Others
5.7.1. Other Applications Market, 2021 - 2033 (USD Million)
Chapter 6. U.S. Exosomes Market Workflow Estimates & Trend Analysis
6.1. U.S. Exosomes Market Workflow Dashboard
6.2. U.S. Exosomes Market Workflow Movement Analysis
6.3. Isolation Methods
6.3.1. Isolation Methods Market, 2021 - 2033 (USD Million)
6.3.2. Ultracentrifugation
6.3.2.1. Ultracentrifugation Market, 2021 - 2033 (USD Million)
6.3.3. Immunocapture On Beads
6.3.3.1. Immunocapture On Beads Market, 2021 - 2033 (USD Million)
6.3.4. Precipitation
6.3.4.1. Precipitation Market, 2021 - 2033 (USD Million)
6.3.5. Filtration
6.3.5.1. Filtration Market, 2021 - 2033 (USD Million)
6.3.6. Others
6.3.6.1. Other Isolation Methods Market, 2021 - 2033 (USD Million)
6.4. Downstream Analysis
6.4.1. Downstream Analysis Market, 2021 - 2033 (USD Million)
6.4.2. Cell Surface Marker Analysis Using Flow Cytometry
6.4.2.1. Cell Surface Marker Analysis Using Flow Cytometry Market, 2021 - 2033 (USD Million)
6.4.3. Protein Analysis Using Blotting & ELISA
6.4.3.1. Protein Analysis Using Blotting & ELISA Market, 2021 - 2033 (USD Million)
6.4.4. RNA Analysis With NGS & PCR
6.4.4.1. RNA Analysis With NGS & PCR Market, 2021 - 2033 (USD Million)
6.4.5. Proteomic Analysis Using Mass Spectrometry
6.4.5.1. Proteomic Analysis Using Mass Spectrometry Market, 2021 - 2033 (USD Million)
6.4.6. Others
6.4.6.1. Other Downstream Analysis Market, 2021 - 2033 (USD Million)
Chapter 7. U.S. Exosomes Market End Use Estimates & Trend Analysis
7.1. U.S. Exosomes Market End Use Dashboard
7.2. U.S. Exosomes Market End Use Movement Analysis
7.3. Pharmaceutical & Biotechnology Companies
7.3.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Million)
7.4. Hospitals & Diagnostics Centers
7.4.1. Hospitals & Diagnostics Centers Market, 2021 - 2033 (USD Million)
7.5. Academic & Research Institutes
7.5.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Categorization
8.2. Company Market Position Analysis, 2025
8.3. Company Profiles
8.3.1. Danaher
8.3.1.1. Company overview
8.3.1.2. Financial performance
8.3.1.3. Product benchmarking
8.3.1.4. Strategic initiatives
8.3.2. Thermo Fisher Scientific, Inc.
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Product benchmarking
8.3.2.4. Strategic initiatives
8.3.3. Hologic Inc.
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Product benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Bio-Techne
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. RoosterBio, Inc
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Fujifilm Holdings Corporation
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Lonza
8.3.7.1. Company Overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Miltenyi Biotec
8.3.8.1. Company Overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. QIAGEN
8.3.9.1. Company Overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. CellBio Scientific
8.3.10.1. Company Overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us